Hart-Scott-Rodino expires on Schein Pharmaceutical Inc. tender offer for Marsam Pharmaceuticals Inc.FLORHAM PARK & CHERRY HILL, N.J.--(HealthWire)--Aug. 22, 1995--Schein Pharmaceutical Inc. and Marsam Pharmaceuticals Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :MSAM MSAM MetaFrame Secure Access Manager (Citrix) MSAM Medium Scale Anisotropy Measurement MSAM Microcomputer Spectrum Analysis Models MSAM Multi-Sequential Access Method MSAM Major System Acquisition Manual MSAM Microsoft Screen Access Model ) announced today that the waiting period under the pre-merger notification requirements of The Hart-Scott-Rodino Antitrust Improvements Act The Hart-Scott-Rodino Antitrust Improvements Act of 1976 (Public Law 94-435, known commonly as the HSR Act) is a set of amendments to the antitrust laws of the United States, principally the Clayton Antitrust Act. The HSR Act was signed into law by President Gerald R. of 1976, in connection with Schein Pharmaceutical's cash tender offer for all the outstanding shares of common stock of Marsam Pharmaceuticals Inc., expired on Saturday, Aug. 19, without a "second request" from the Federal Trade Commission for additional information or documentary materials. Schein Pharmaceutical's cash tender offer to purchase all the outstanding shares of Marsam's common stock at $21.00 per share expires at midnight, New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. time, on Sept. 1, 1995, unless extended. CONTACT: Schein Pharmaceutical Inc. Suzanne Soderberg 201/593-5565 or Marsam Pharmaceuticals Inc. Richard A. Baron 609/424-5600 x320 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion